Analytical Data
-
Gene name
CES5A
- Application
-
Alternative Names
CES7; CES4C1; CES5; CAUXIN; Carboxylesterase-like urinary excreted protein homolog
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6NT32
-
Expression Region
His383~Phe570
-
Molecular Weight
54kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CES5A (Carboxylesterase 5A) is a member of the carboxylesterase enzyme family, which plays a vital role in the hydrolysis of various ester compounds, including drugs and environmental toxins. The study of CES5A has gained importance due to its potential implications in pharmacology, toxicology, and biochemistry. Recent research highlights its involvement in drug metabolism and bioactivation processes, which are critical for understanding individual responses to medications and chemical exposures. Variations in CES5A expression and activity can lead to differences in drug efficacy and toxicity among individuals, making it a crucial target for personalized medicine approaches. Furthermore, the enzyme's ability to degrade esters makes it relevant in the biodegradation of environmental pollutants, suggesting potential applications in bioremediation. Investigating the structure, function, and regulation of CES5A helps elucidate its biological roles and enhances our understanding of metabolic pathways. Researchers are also exploring the development of CES5A-based biomarkers and therapeutic agents, aiming to leverage its enzymatic capabilities for clinical advancements. Overall, the ongoing study of CES5A and its recombinant forms is essential for advancing therapeutic strategies and addressing environmental challenges.
